PKAN, AREA[OverallStatus], Open or Pending: 4 Clinical Trials

Include Studies Not Open or Pending

2

TIRCON International NBIA Registry

Condition(s):Neurodegeneration With Brain Iron Accumulation (NBIA); Pantothenate Kinase-associated Neurodegeneration (PKAN); Beta-Propeller Protein-Associated Neurodegeneration (BPAN); Mitochondrial Membrane Protein Associated Neurodegeneration (MPAN); Fatty Acid Hydroxylase-associated Neurodegeneration (FAHN); Kufor Rakeb Syndrome; Neuroferritinopathy; Aceruloplasminemia; Woodhouse Sakati Syndrome; COASY Protein-associated Neurodegeneration (CoPAN); PLA2G6-Associated Neurodegeneration (PLAN)Last Updated:December 21, 2023Recruiting

3

Longitudinal Study of Neurodegenerative Disorders

Condition(s):MLD; Krabbe Disease; ALD; MPS I; MPS II; MPS III; Vanishing White Matter Disease; GM3 Gangliosidosis; PKAN; Tay-Sachs Disease; NP Deficiency; Osteopetrosis; Alpha-Mannosidosis; Sandhoff Disease; Niemann-Pick Diseases; MPS IV; Gaucher Disease; GAN; GM1 Gangliosidoses; Morquio Disease; S-Adenosylhomocysteine Hydrolase Deficiency; Batten Disease; Pelizaeus-Merzbacher Disease; Leukodystrophy; Lysosomal Storage Diseases; Purine Nucleoside Phosphorylase Deficiency; Multiple Sulfatase Deficiency DiseaseLast Updated:November 4, 2021Recruiting

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.